{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:08:18Z","timestamp":1791241698535,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.ajog.2011.06.049","type":"journal-article","created":{"date-parts":[[2011,6,25]],"date-time":"2011-06-25T20:27:05Z","timestamp":1309033625000},"page":"480.e1-480.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Natural history and outcome of mucinous carcinoma of the ovary"],"prefix":"10.1016","volume":"205","author":[{"given":"Maria B.","family":"Schiavone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharyn N.","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Deutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2011.06.049_bib1","first-page":"277","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajog.2011.06.049_bib2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s12094-010-0599-0","article-title":"Classification of ovarian carcinomas based on pathology and molecular genetics","volume":"12","author":"D'Angelo","year":"2010","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ajog.2011.06.049_bib3","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.humpath.2009.04.017","article-title":"Ovarian carcinoma pathology and genetics: recent advances","volume":"40","author":"Gilks","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajog.2011.06.049_bib4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajog.2011.06.049_bib5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0090-8258(03)00264-6","article-title":"Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma","volume":"90","author":"Gemignani","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2011.06.049_bib6","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/sj.bjc.6603003","article-title":"A distinct molecular profile associated with mucinous epithelial ovarian cancer","volume":"94","author":"Heinzelmann-Schwarz","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2011.06.049_bib7","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1200\/JCO.2004.08.078","article-title":"Mucinous epithelial ovarian cancer: a separate entity requiring specific treatment","volume":"22","author":"Hess","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajog.2011.06.049_bib8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ygyno.2005.10.008","article-title":"Primary and metastatic mucinous adenocarcinomas of the ovary: evaluation of the diagnostic approach using tumor size and laterality","volume":"101","author":"Khunamornpong","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2011.06.049_bib9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2009.02.010","article-title":"Clinicopathological characteristics of mucinous adenocarcinoma of the ovary","volume":"113","author":"Shimada","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2011.06.049_bib10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.pgp.0000130446.84670.93","article-title":"Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data","volume":"23","author":"Gilks","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ajog.2011.06.049_bib11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ygyno.2010.02.010","article-title":"Unmasking the complexities of mucinous ovarian carcinoma","volume":"117","author":"Frumovitz","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2011.06.049_bib12","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/02841860701784544","article-title":"Survival in ovarian cancer patients by histology and family history","volume":"47","author":"Ji","year":"2008","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ajog.2011.06.049_bib13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/1471-2407-8-252","article-title":"Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study","volume":"8","author":"Pignata","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ajog.2011.06.049_bib14","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/00000478-200307000-00014","article-title":"Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis","volume":"27","author":"Seidman","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajog.2011.06.049_bib17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ygyno.2009.09.029","article-title":"Tumor type and substage predict survival in stage I and II ovarian carcinoma: insights and implications","volume":"116","author":"Kobel","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2011.06.049_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.pgp.0000101080.35393.16","article-title":"The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin","volume":"23","author":"Seidman","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ajog.2011.06.049_bib19","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/cncr.10415","article-title":"Ethnic differences in survival among women with ovarian carcinoma","volume":"94","author":"Barnholtz-Sloan","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2011.06.049_bib20","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/(SICI)1097-0142(19970815)80:4<816::AID-CNCR21>3.0.CO;2-V","article-title":"The National Cancer Data Base report on malignant epithelial ovarian carcinoma in African-American women","volume":"80","author":"Parham","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2011.06.049_bib21","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","article-title":"Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study","volume":"25","author":"Winter","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajog.2011.06.049_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0303-7207(03)00069-8","article-title":"Genetic alterations in ovarian carcinoma: with specific reference to histological subtypes","volume":"202","author":"Fujita","year":"2003","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ajog.2011.06.049_bib23","first-page":"1489","article-title":"Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy","volume":"53","author":"Mok","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajog.2011.06.049_bib24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/humu.10181","article-title":"TP53 and ovarian cancer","volume":"21","author":"Schuijer","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ajog.2011.06.049_bib25","doi-asserted-by":"crossref","first-page":"7850","DOI":"10.1158\/1078-0432.CCR-08-0523","article-title":"Analysis of gene expression in early-stage ovarian cancer","volume":"14","author":"Marchini","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajog.2011.06.049_bib26","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ygyno.2004.12.056","article-title":"Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience","volume":"97","author":"Pectasides","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2011.06.049_bib27","first-page":"3501","article-title":"Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective study","volume":"25","author":"Pisano","year":"2005","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ajog.2011.06.049_bib28","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/IGC.0b013e3181ee1c01","article-title":"Current academic clinical trials in ovarian cancer: Gynecologic Cancer Intergroup (GCIG) and United States National Cancer Institute (NCI) clinical trials planning meeting, May, 2009","volume":"20","author":"Trimble","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2011.06.049_bib29","first-page":"99","article-title":"Cytotoxic agents active against mucinous adenocarcinoma of the ovary","volume":"5","author":"Shimizu","year":"1998","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ajog.2011.06.049_bib30","first-page":"650","article-title":"A phase II study of combined CPT-11 and mitomycin-C in platinum refractory clear cell and mucinous ovarian carcinoma","volume":"27","author":"Shimizu","year":"1998","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.ajog.2011.06.049_bib31","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/cncr.24915","article-title":"Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum-paclitaxel chemotherapy","volume":"116","author":"Bamias","year":"2010","journal-title":"Cancer"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937811007770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937811007770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:41:55Z","timestamp":1757587315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937811007770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0002937811007770"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2011.06.049","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural history and outcome of mucinous carcinoma of the ovary","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2011.06.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}